| Filed On | Filing |
|---|---|
| 12 Dec 2022 |
8-K/A: Financial Statements and Exhibits
Effective October 20, 2022, Sunshine Biopharma, Inc. (“Sunshine” or the “Company”) entered into a Share Purchase Agreement with Nora Pharma Inc. (the “Nora Purchase Agreement”), wherein the Company acquired all of the issued and outstand... |
| 09 Aug 2016 | 8-K/A: Unregistered Sales of Equity Securities |
| 07 Feb 2012 | 8-K/A: Changes in Registrant's Certifying Accountant |
| 19 Jan 2010 | 8-K/A: Completion of Acquisition or Disposition of Assets; Unregistered Sales of Equity Securities +2 more |
Loading...
